Medical device development is no longer centered on a static product. It is increasingly centered on systems, where hardware, software, data, connectivity, and AI collectively determine performance. This shift is not just expanding technical scope. It is changing what must be designed, controlled, and justified from a regulatory perspective.

As a result, a new form of risk is emerging……Regulatory debt.

From Fixed Devices to Conditioned Systems:

Historically, device performance could be bounded by design inputs and verified against defined outputs. Even in complex electromechanical systems, behavior was intended to be deterministic within known conditions.

That assumption is weakening.

In modern devices, performance is influenced by factors beyond the physical system. Software state and versioning, data inputs and preprocessing, network conditions, cybersecurity controls, and AI model behavior all play a role.

Performance is no longer purely designed. It is conditioned by the system in which the device operates.

Where Traditional Development Breaks Down:

Regulatory frameworks have always required alignment between design inputs, risk management under ISO 14971, verification and validation, and design outputs with full traceability.

What has changed is the difficulty of maintaining that alignment across a distributed system.

When development remains siloed, gaps begin to emerge. Software evolves faster than requirements and risk documentation. Data flows are not fully captured in design inputs. Cybersecurity is addressed after architecture decisions are made. AI components are introduced without clearly defined validation strategies. Individually manageable. Collectively, they create systems that are difficult to fully characterize and justify under regulatory scrutiny.

Defining Regulatory Debt:

This is where new forms of risk begin to take place. Regulatory debt is the accumulation of decisions that reduce the ability to demonstrate that a system is fully understood and controlled. This includes the ability to maintain traceability, align system behavior with intended use, validate performance across relevant conditions, and manage changes throughout the lifecycle.

It is not simply a documentation problem.

It reflects a deeper issue. A growing gap between how the system actually behaves and how it is formally defined, validated, and controlled.

Where Regulatory Debt Accumulates:

In converged systems, regulatory debt builds at the interfaces between disciplines.

Within the software lifecycle under IEC 62304, iterative development can outpace documentation, hazard analysis, and verification, creating gaps between implemented functionality and controlled requirements.

Within risk management under ISO 14971, hazard analyses may not fully capture system-level interactions such as software faults, data dependencies, or cybersecurity threats that impact safety and effectiveness.

Cybersecurity expectations now emphasize secure by design principles, including threat modeling, software bill of materials, and lifecycle vulnerability management. When introduced late, these are difficult to align with existing architecture.

AI adds further complexity. Without clearly defined model boundaries, monitoring strategies, and change control approaches such as emerging Predetermined Change Control Plan concepts, validation becomes incomplete.

At the same time, connected systems blur the definition of the device, and gaps in data integrity, provenance, and transformation make it harder to demonstrate reliable performance within intended use.

How Regulatory Debt Surfaces:

Regulatory debt rarely appears during early development. It becomes visible during design verification, validation, and submission preparation.

Traceability matrices become difficult to complete or defend. Risk controls cannot be clearly linked to actual system behavior. Validation expands beyond its original scope because system conditions were not fully defined. Questions arise regarding system boundaries, especially for cloud connected or data driven components. AI enabled features lack sufficient transparency or performance justification.

At this point, the challenge is no longer isolated gaps.

It is the realization that the system cannot be fully explained, bounded, or controlled in a way that meets regulatory expectations.

Why This Is a Patient Safety and Efficacy Issue:

Regulatory debt is often framed as a timeline or submission risk. That framing is incomplete.

In these systems, uncertainty is not just technical. It is clinical.

A system may behave differently under untested network conditions. An AI model may perform inconsistently across patient populations that were not well represented in training data. A software update or security patch may introduce unintended changes in system behavior. Data dependencies may create edge cases that were not fully captured in risk analysis.

Individually, these scenarios may appear unlikely. Collectively, they determine whether a device is safe and effective across real world use. In this context, the standard is no longer that the device works under controlled conditions.

The standard is that the system performs reliably within clearly defined and controlled boundaries.

The Expanding Evidentiary Burden:

Regulators are increasingly focused on the ability to demonstrate end to end system understanding.

This includes clear definition of intended use and system boundaries, robust software lifecycle processes, comprehensive risk management across system interactions, and sustained control over changes throughout the product lifecycle.

For software driven and AI enabled devices, this represents a shift toward lifecycle assurance rather than point in time validation. The expectation is not only that the system works, but that it can be trusted to continue working as intended as conditions change.

What This Means for Development:

Avoiding regulatory debt requires a shift in how development is approached.

This is not about adding more documentation. It is about alignment from the start. System architecture, software behavior, data flows, risk management, and cybersecurity must be defined early, with clear system boundaries and lifecycle control built in. Traceability must be continuous, not reconstructed at the end.

It also requires a change in mindset. Development is no longer about progressing through phases. It is about maintaining control over a system that must remain understandable and reliable as it evolves.

In this environment, regulatory strategy is no longer separate from development. It is part of system design.

The convergence of AI, software, and hardware is redefining what it means to demonstrate safety and effectiveness. Regulatory debt is what happens when system complexity outpaces control. And when that gap exists, the real risk is not delay or rework. It is uncertainty in how the system performs when it matters most.